Nvigen
Sunnyvale, California, United States
About Nvigen
NVIGEN is a nanobiotechnology company revolutionizing the field of multifunctional nanoparticles for biomedical applications. Their pipeline of visionary solutions stems from our proprietary nanochemistry technology. NVIGEN was founded in the heart of Silicon Valley, from technologies that culminated from years of rigorous research at the University of California, Berkeley, and Stanford University. NVIGEN develops nanoparticle research reagents and devices for biomedical research applications. NVIGEN was incorporated in 2011.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $1.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2014)
- Website: nvigen.com
- Phone: (408) 970-9988
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/nvigen-2253221 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.